Autres langues GENinCode Plc

Actions

GENI

GB00BL97B504

Temps Différé London S.E. Autres places de cotation 08:59:59 16/07/2024			Varia. 5j.	Varia. 1 janv.
6,25 ^GBX	0,00 %		-7,41 %	+19,05 %

04/06	Transcript : GENinCode Plc, 2023 Earnings Call, Jun 04, 2024
03/06	Le chiffre d'affaires de GENinCode augmente grâce à une expansion internationale continue	AN

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

GENinCode revenue grows amid continued international expansion	03/06
FTSE 100 to be up before manufacturing data	03/06
GENinCode Plc Reports Earnings Results for the Full Year Ended December 31, 2023	03/06
GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort	04/04
GENinCode says ROCA recommended as ovarian cancer risk test in England	21/03
GENinCode gets GBP57,000 in retail offer, well below maximum	28/12
GENinCode Raises GBP4 Million from Share Sale	28/12
GENinCode raises GBP4 million via placing and subscription	21/12
Genincode Plc Announces Placing And Subscription To Raise A Minimum Of £4.0 Mln	21/12
Aura eyes Tiris expansion; Kavango backs Pambili	29/11
GENinCode plc Agrees with the Food and Drug Administration to Create New Regulatory Class for Polygenic Risk scores and Transition Its Premarket Notification 510(K) Submission to A De Novo Pathway	29/11
EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up	20/09/23
Earnings Flash (GENI.L) GENINCODE Reports H1 Revenue GBP950,000	20/09/23
Earnings Flash (GENI.L) GENINCODE Posts H1 Loss GBX-3.33	20/09/23
GENinCode Plc Provides Revenue Guidance for the Second Half of 2023	20/09/23
GENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2023	20/09/23
Genincode plc Announces CARDIO inCode study on risk of incident Coronary Heart Disease	30/08/23
GENinCode Shares Rise on FDA Filing for Heart Disease Test Kit	16/08/23
GENinCode Submits Premarket Notification for US Commercial Distribution of Polygenic Test Kit	16/08/23
GENinCode plc Files its Premarket Notification with the Food and Drug Administration to Expand Its US Commercial Distribution of the Cardio InCode-Score Polygenic Test for the Risk Assessment and Prevention of Coronary Heart Disease	16/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues GENinCode Plc

Actions

GENI

GB00BL97B504

Autres langues

Filtres